Showing 2441-2450 of 7240 results for "".
Prescribing Pitfalls, Part I: Navigate the Changing Landscape of Brand Name Drug Prescribing
https://practicaldermatology.com/topics/practice-management/prescribing-pitfalls-part-i-navigate-the-changing-landscape-of-brand-name-drug-prescribing/21440/Prescribers increasingly need to understand drug pricing, pharmacy policies, insurance coverage, and coupon offers to ensure patients get the medications they need.Goal Alignment: Complementary Goals Produce Desired Practice Outcomes
https://practicaldermatology.com/topics/practice-management/goal-alignment-complementary-goals-produce-desired-practice-outcomes/21493/Suggested steps managers can take to increase efficiency and improve productivity.Blunt Tip Microcannulas- No Bruise Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dermasculpt-injectable-fillers-no-bruise-fillers/19280/Dr. Kian Karimi MD describes the blunt cannula for injectable fillers. Finally, a way to perform fillers with truly minimal risk of bruising, far less swelling, and less pain than traditional injection techniques. All fillers including Juvederm, Restylane, Perlane, and Radiesse can be injected usinNeurotoxin Tips for Beginners and Advanced Users
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxin-tips-for-beginners-and-advanced-users/21578/Experts from the international aesthetics arena share pearls for maximizing neurotoxins.EHR Use in Dermatology: Where We Stand
https://practicaldermatology.com/topics/practice-management/ehr-use-in-dermatology-where-we-stand/21624/CMS released data for EHR use in 2011, but next year's data will likely determine the role EHRs will play in the future of dermatology.New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21647/New Products and Pharmacologic Advancements
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-advancements/21663/Upadacitinib and Cardiovascular Events in AD
https://practicaldermatology.com/issues/october-2025/upadacitinib-and-cardiovascular-events-in-ad/39755/A recent review examined whether upadacitinib, a selective Janus kinase 1 (JAK1) inhibitor approved for atopic dermatitis (AD) and other chronic inflammatory diseases, may—despite a boxed warning to the contrary—confer cardioprotective and thromboprotective effects.Bipolar Radiofrequency Microneedling for the Treatment of Facial Lipoma: A Case Study
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/bipolar-radiofrequency-microneedling-for-the-treatment-of-facial-lipoma-a-case-study/24001/Clara Barranco, MD, Rachel Murray, DO, Karthik Krishnamurthy, DO, Alexandra Lawlor BS, and Mary Pentel, MDExosomes: The Next Big Thing in Skincare?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/exosomes-the-next-big-thing-in-skincare/23684/There is still a lot to learn, but early evidence suggests that topically applied exosomes may transform the approach to skincare.